Charles Mosseri - May 6, 2025 Form 4/A - Amendment Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Stock symbol
NVCT
Transactions as of
May 6, 2025
Transactions value $
$247,263
Form type
4/A - Amendment
Date filed
5/12/2025, 09:25 AM
Date Of Original Report
May 9, 2025
Previous filing
Feb 11, 2025
Next filing
May 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mosseri Marlio Charles 10%+ Owner 27 RIPPLEVALE GROVE, LONDON, LIBYAN ARAB JAMAHIRIYA /s/ Charles Mosseri-Marlio 2025-05-12 0001806384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $899 +100 +0% $8.99 2.91M May 8, 2025 By Emerald Hill Ventures SARL SPF. F1, F2
transaction NVCT Common Stock Purchase $871 +100 +0% $8.71 2.91M May 8, 2025 By Emerald Hill Ventures SARL SPF. F1, F2
transaction NVCT Common Stock Purchase $21.5K +2.4K +0.08% $8.97 2.91M May 8, 2025 By Emerald Hill Ventures SARL SPF. F1, F2
transaction NVCT Common Stock Purchase $88.1K +9.85K +0.34% $8.95 2.92M May 9, 2025 By Emerald Hill Ventures SARL SPF. F1, F3
transaction NVCT Common Stock Purchase $87.4K +9.82K +0.34% $8.90 2.93M May 9, 2025 By Emerald Hill Ventures SARL SPF. F1, F3
transaction NVCT Common Stock Purchase $48.4K +5.4K +0.18% $8.98 2.94M May 9, 2025 By Emerald Hill Ventures SARL SPF. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
F2 The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions.
F3 The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025.